Clinical Report: The Dual Role of TREM2 in Fibrosis
Overview
This review explores the dual role of TREM2 in organ fibrosis, highlighting its influence on macrophage polarization and tissue repair mechanisms. It emphasizes the organ-specific effects of TREM2, which can either promote or inhibit fibrosis depending on the context, as supported by various studies.
Background
Organ fibrosis is a significant consequence of chronic diseases, resulting from the interplay between inflammation and tissue repair. Understanding the mechanisms governing fibrosis is crucial for developing targeted therapies. TREM2, a receptor on myeloid cells, plays a pivotal role in regulating these processes, as evidenced by its contradictory roles across different organs.
Data Highlights
No numerical data or trial data presented in the article.
Key Findings
TREM2 is primarily expressed on macrophages and regulates inflammation and fibrosis, as shown in multiple studies.
In liver fibrosis, TREM2 enhances collagen degradation and inhibits hepatic stellate cell activation, according to specific research.
In pulmonary fibrosis, TREM2 expression correlates positively with fibrosis severity, based on recent findings.
TREM2's role in fibrosis is influenced by its ability to modulate macrophage polarization and immunometabolic reprogramming, as indicated in the literature.
Soluble TREM2 (sTREM2) has potential as a dynamic biomarker in fibrotic diseases, supported by current research.
Clinical Implications
Understanding the organ-specific roles of TREM2 could inform the development of tailored interventions, as suggested by recent studies.
Conclusion
The dual role of TREM2 in fibrosis highlights the complexity of macrophage interactions in different organ contexts, necessitating further research to clarify its roles.
